Detection of diabetic nephropathy from advanced glycation endproducts (AGEs) differs in plasma and urine, and is dependent on the method of preparation

[1]  P. Beisswenger.  Glycation and biomarkers of vascular complications of diabetes , 2012, Amino Acids.

[2]  Samy Suissa,et al.  Renal and retinal effects of enalapril and losartan in type 1 diabetes. , 2009, The New England journal of medicine.

[3]  A. Krolewski,et al.  Early nephropathy in type 1 diabetes: the importance of early renal function decline , 2009, Current opinion in nephrology and hypertension.

[4]  W. Cefalu,et al.  Glycemic targets and cardiovascular disease. , 2008, The New England journal of medicine.

[5]  G. McMahon,et al.  Intensive glycemic control in the ACCORD and ADVANCE trials. , 2008, The New England journal of medicine.

[6]  L. Monnier,et al.  Contributions of fasting and postprandial glucose to hemoglobin A1c. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[7]  R. Nelson,et al.  Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. , 2005, Diabetes.

[8]  Paul J Thornalley,et al.  Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes. , 2005, Diabetes care.

[9]  M. Kramer,et al.  The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. , 2005, Diabetes.

[10]  Paul J Thornalley,et al.  Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes , 2005, Diabetologia.

[11]  S. Genuth,et al.  Glycation Products as Markers and Predictors of the Progression of Diabetic Complications , 2005, Annals of the New York Academy of Sciences.

[12]  Michael Brownlee,et al.  The pathobiology of diabetic complications: a unifying mechanism. , 2005, Diabetes.

[13]  M. Hanefeld,et al.  Postprandial glucose regulation and diabetic complications. , 2004, Archives of internal medicine.

[14]  M. F. Saad,et al.  Familial predisposition to renal disease in two generations of Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus , 1990, Diabetologia.

[15]  S. Kreiner,et al.  Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study , 1983, Diabetologia.

[16]  A. Goldberg,et al.  Protein degradation and protection against misfolded or damaged proteins , 2003, Nature.

[17]  Anne Dawnay,et al.  Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. , 2003, The Biochemical journal.

[18]  M. Kramer,et al.  Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy. , 2003, Diabetes.

[19]  Matthew D. Davis,et al.  Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. , 2002, JAMA.

[20]  Michael E. Miller,et al.  Erratum: Cellular basis of diabetic nephropathy. 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes (Diabetes (2002) 51 (506-513) , 2002 .

[21]  M. Mauer,et al.  The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. , 2002, Diabetes.

[22]  M. Mauer,et al.  The early natural history of nephropathy in type 1 diabetes: I. Study design and baseline characteristics of the study participants. , 2002, Diabetes.

[23]  D. Goldstein,et al.  Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. , 2002, Diabetes care.

[24]  Michael E. Miller,et al.  Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. , 2002, Diabetes.

[25]  B. Szwergold,et al.  alpha-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia. , 2001, Diabetes care.

[26]  M. Mauer,et al.  The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? , 2000, Diabetes.

[27]  R. Holman,et al.  Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. , 1999, JAMA.

[28]  S. Rich,et al.  Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs. , 1999, Diabetes.

[29]  Clustering of Long-Term Complications in Families With Diabetes in the Diabetes Control and Complications Trial , 1997, Diabetes.

[30]  D. Malencik,et al.  Dityrosine: preparation, isolation, and analysis. , 1996, Analytical biochemistry.

[31]  M. Steffes,et al.  Glomerular Structure in Nonproteinuric IDDM Patients With Various Levels of Albuminuria , 1994, Diabetes.

[32]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[33]  E. Seaquist,et al.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. , 1989, The New England journal of medicine.

[34]  J. Flier,et al.  Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. , 1987, The New England journal of medicine.

[35]  H. Klocker,et al.  Measurement of glycated protein by a rapid and specific method for absolute quantification of lysine-bound glucose. , 1987, Clinical chemistry.

[36]  C. Mogensen,et al.  Predicting diabetic nephropathy in insulin-dependent patients. , 1984, The New England journal of medicine.

[37]  D. Wilson,et al.  Vitreous fluorophotometry: identification of sources of variability. , 1981, Investigative ophthalmology & visual science.

[38]  H. Mcilwain,et al.  Preparation and antibacterial action of some compounds structurally related to glutamic acid. Their application in microbiological determination of small quantities of glutamine. , 1948, The Biochemical journal.